nsc 664704 has been researched along with Hepatitis D in 1 studies
kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).
Hepatitis D: INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchmann, B | 1 |
| Döhner, K | 1 |
| Schirdewahn, T | 1 |
| Sodeik, B | 1 |
| Manns, MP | 1 |
| Wedemeyer, H | 1 |
| Ciesek, S | 1 |
| von Hahn, T | 1 |
1 other study available for nsc 664704 and Hepatitis D
| Article | Year |
|---|---|
A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection.
Topics: Antibodies, Monoclonal; Antiviral Agents; Automation; Benzazepines; Coinfection; Hepatitis Antibodie | 2017 |